Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 November 2021 | Story Elna Van Pletzen

The Council of the University of the Free State (UFS) is seeking to co-opt a suitable candidate to serve for a period of four (4) years on the Finance Committee of Council. To this end, nominations for suitably qualified and experienced candidates are invited.

The Finance Committee of Council exercises oversight over the financial and investment portfolio of the UFS.

Candidates must be suitably qualified with requisite knowledge and experience of financial matters (including investments and acquisitions that are material to the UFS’s business). An appropriate qualification in the financial field is required, as is registration with the relevant professional bodies. 

Nominations must be submitted on the prescribed Nomination form, together with detailed curricula vitae, to the Registrar of the UFS at registrar@ufs.ac.za before 16:30 on 12 January 2022.

The Nominations Committee of Council will consider all the nominations and make a recommendation to the Council, which will decide whether to co-opt any of the candidates. 

The Finance Committee meets at least four times per year, or more frequently as may be necessary. 

The Council may decide not to co-opt any of the candidates.  

For enquiries, you may contact Mr NN Ntsababa at registrar@ufs.ac.za or telephone number +27 51 401 3796.

News Archive

UFS researcher explores the future cost of cancer
2017-01-10

 Description: 001 Dr Alicia Sherriff Tags: 001 Dr Alicia Sherriff

Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.

Photo: Charl Devenish

Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.

Cancer is on the rise

There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.

The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.

Adoption of new strategies

According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.

Efficient solutions to curb cancer mortality

The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept